NCT06104566Phase 3Recruiting

Global Trial in APG2575 for Patients With CLL/SLL

Study sponsor: Ascentage Pharma Group Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-12-31Estimated

Enrollment · participants400Estimated

Source updated2026-06-18Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-06-18 · 1 field changed

Primary completion date changed

− Before

~~20 Oct 2025~~

+ After

31 Dec 2026

Check registry source